Table 5. Kaplan–Meier Survival Estimates and Log-Rank Test Results for Cardiovascular Outcomes.

CMD: coronary microvascular dysfunction

*p < 0.05 considered statistically significant

Outcome	Event Rate CMD Present	Event Rate CMD Absent	Median Event-Free Survival (Months)	Log-Rank χ²	p-value	Hazard Ratio (HR)	95% CI
Major Adverse Cardiovascular Events (MACE)	29.7%	10.4%	CMD: 19.5 vs. Non-CMD: >24	13.82	<0.001*	2.41	1.39–4.16
Myocardial Infarction	11.7%	4.4%	CMD: 21.3 vs. Non-CMD: >24	4.76	0.029*	2.28	1.01–5.16
Heart Failure Hospitalization	17.2%	5.2%	CMD: 20.7 vs. Non-CMD: >24	8.27	0.004*	2.85	1.19–6.80
Cardiovascular Death	7.8%	2.6%	CMD: 22.8 vs. Non-CMD: >24	3.45	0.063	2.94	0.82–10.53
All-Cause Mortality	14.1%	6.1%	CMD: 21.6 vs. Non-CMD: >24	4.18	0.041*	2.34	1.01–5.42